Authors: Ferrero, D Foli, C Giaretta, F Argentino, C Rus, C Pileri, A

Citation: D. Ferrero et al., Growth advantage of chronic myeloid leukemia CFU-GM in vitro: survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids +/- alpha-interferon, LEUKEMIA, 15(3), 2001, pp. 422-429

Authors: Boccadoro, M Omede, P Dominietto, A Palumbo, A Bringhen, S Giaretta, F Ortolano, B Triolo, S Pileri, A

Citation: M. Boccadoro et al., Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support, BONE MAR TR, 25(1), 2000, pp. 25-29

Authors: Tarella, C Corradini, P Astolfi, M Bondesan, P Caracciolo, D Cherasco, C Ladetto, M Giaretta, F Ricca, I Vitolo, U Pileri, A Ferrero, D

Citation: C. Tarella et al., Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions, LEUKEMIA, 13(9), 1999, pp. 1456-1462

Authors: Ferrero, D Cherasco, C Ortolano, B Giaretta, F Bruno, B

Citation: D. Ferrero et al., In vitro growth and quantification of early (CD33(-)/CD38(-)) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy, HAEMATOLOG, 84(5), 1999, pp. 390-396